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Synopsis: 
There have been several attempts to generate an effective treatment against HIV, the 
causative organism for AIDS. However till to date no drug or vaccine is able to neutralize 
a broad spectrum of HIV-1 primary isolates. Entry of the virus into the host cell is 
mediated by the interaction of the envelope (env) glycoprotein subunit gp120 expressed 
on the viral surface and host T-cell receptor CD4. The interaction between gp120 and 
CD4, which is predominantly hydrophobic in nature, leads to conformational changes in 
gp 120 (Sattentau and Weiss 1988; Sattentau and Moore 1991; Bachelder et al. 1995) 
causing the previously buried cryptic epitopes (CD4i) in gp120 to get exposed. This 
promote binding of gp 120 to its co-receptor CCR5 (Trkola et al. 1996; Wu et al. f 996). 
Further conformational changes in the gp41 subunit of env lead to fusion of the viral and 
target cell membranes and subsequent entry of the viral genome into the host cell 
(Blacklow et al. 1995; Lu et al. 1995; Moore et al. 1997; Eckert and Kim 20Olb). There 
have been numerous attempts to develop an inhibitor or a vaccine that could be effective 
against diverse isolates of HIV. The main reasons for the failure in the development of 
such an agent is because of the high mutability of HIV, extensive glycosylation of gp120, 
shielding of neutralizing epitopes by variable loops and significant alteration in the 
tertiary structure of envelope protein after interaction with CD4. The crystal structures of 
unIiganded form of the gp120 core (Chen et al. 2005)and the ternary complex of gp120 
care with its primary receptor C1)4 and the neutralizing antibody 17b Fab fragment 
(gp120-CD4-1%) ase known (Kwong et aI, 1998; Kwong et al. 2W). 
The long tern1 aim of the work reported In this thesis is to devtlop suitable immunogcns 
and inhibitors that are able to result in neutralization of different primary isolates of HIV. 
Thcsc approaches are based upon the available crystal structure of gpl20-CD4- 17b. 
Abbreviations : HIV, Hunlan i~llnlunodeficicncy virus; CD, circular dichroism; GdnC1, 
Guanidinium chloride; CD4D12, two N-terminal domains of human CD4 (amino acids 1- 
1'3); CD4D1; first N-terminal domain of human CM (amino acids 1~99); CD4D-I (S-S j, 
CD4D I with an additional disulfide; CD4PEP i ,  region 2 1 to 64 af human CD4. 
Chapter 1 discusses general aspects about the structural organization of HIV, its life 
cycle and the mechanism of entry into the target cell. It describes the various approaches 
adopted to neutralize the virus and the main hindrances to develop an effective vaccine or 
drug against it. 
Chapter 2 describes the expression, purification and thermodynamic characterization of 
several analogs of human CD4. Equilibrium unfolding of these derivatives by 
Guanidinium chloride (GdnCl) was monitored by a combination of fluorescence and 
circular dichroism spectroscopy. CD4D12 shows a multistep folding pathway and 
revealed the existence of partially folded intermediate states in the unfolding by GdnCl. 
Thermal denaturation of CD4D12 was found to be irreve;rsible and resulted in the 
formation af a visible precipitate. CD4D12, CD4D1, CD4Dl(S-S) show a non- 
cooperative transition for chemical denaturation. These derivatives of CD4 have high 
affmity for gp120 and are able to expose the neutralizing epitope 17b of gp 120. This 
study provides a fmmework to generate CD$ am3.ogs with improved stability. 
Chrtpbr 3 describes the design and s t r u c ~ l  characterization of truncated versions of 
human CD4. Analysis of the gp 1204D4-1% crystat stnrckue showed that m t  of the: 
. 
residues important for binding ts gp 120 lie i~ region 2 31-64 af domain D 1 of CM. E3wd 
upon the a acomputatiand analysis crf the crystal smW, a dad 
designed to express CMD 1 and region 2 1 4 4  sf f;T)4 (CMPEP' 1) in E-cdi.. 'I%e b 
affinity of each CD4 dcribativc and the previously dcsigncd M33 (Martin ct al. 2003) for 
gp 120 was measured using surface plasmon resonance. Mcasurcd KD's wcrc 15nM, 
40nM, 340nM and 26pM for CD4D12, CD4D1, M33 and CD4PEPI respectively. The 
aggrcgation behavior of all thc constructs was charactcrizcd. CD4D12 alone was found to 
form anlyloid like fibrils at neutral pH within 5-6 days at room temperature. The Effect of 
osmolytes on the structure and stability of CD4D12, CD4Dl and CD4DI(S-S) and 
CD4PEPI was studied using CD, fluorescence en~ission spectroscopy and protease 
digstion. 'Both CD4D 1 and -CD4PEPf' were-partiaily structured Safid showed enhance6 
structure in the presence of the osmolyte sarcosine. These CD4 derivatives should be 
useful tools in HIV vaccine design and entry inhibition studies. 
Chapter 4 describes the design and characterization of a trin~eric version of CD4M9. 
M9 is a 27 residue CD4 analog based on a scyllatoxin scaffold (Vita et al. 1999). 
Monomeric CD4M9 is known to bind to gp120 with binding affinity 100 fold weaker 
than CD4~l~(Vita et al. 1999). The GCN4 derived peptide (Eckert and Kim 2001a)has 
been shown to form a trimeric coiled coil. To hrther increase the thermodynamic 
stability of the coiled coil, disulfides were introduced at either the N-terminus (CCIZ) or 
C-terminus (1ZCC)of the peptide. Mass spectrometry and DTNB assay confirmed the 
formation of the disulfides. Introduction of disuIfides resulted in an increase in stability 
of the coiled coil against chemical as well as thermal denaturation. Denaturation of IZ 
and IZCC were found to be >95% reversible for chemical as well as thermal 
denaturation. Chemical (GdnC1) denaturation of CCIZ was > 95% reversible but thennal 
denaturaion was completely irreversible. IZCC was chosen as the trimeric motif for the 
trimerization of CD4M9 because of its well defined helical structure, higher 
thermodynamic stability than IZm and mversibility against both thermal as well as 
chemical denaturation. Moreover the C-terminal of CMM9 points away from gp120 and 
therefore addition of IZCC at the C-terminus of CWM9 would not interfere with 
binding of CMM9 to gp120. CD spectra showed that CDSCM9-IZCC was predominantly 
helical. Size exclusion chromatography indicated the p m n c e  of trimeric species. Mitss 
spectrometry c o n h e d  the formation of trkmie as well as dimefic species C O ~  
by intersubunit disutfb. The Activity of M9-IZC was fioaa- mirig SPR am4 
molcculc was found to bc able to cxposc 17b epitope of gp120. Future studies will use 
the trinlcric M9-IZCC as an inhibitor for H1V entry into host cells. 
Chapter 5 describes the construction and in~n~unological characterization of single chain 
derivatives of JRFL gp120 linked to the first two donlains of human CD4 and to the CD4 
miniprotein analog, CD4M9. Binding affinities of the single chain derivatives to 17b was 
determined using SPR. gp120-CD4D12 and gp 120-M9 bound to the antibody 17b with 
a s  of 0;8 nM 2nd 25 nN respectiveiy-at pH -7.0 while-gp3-20 aione~did not *bind.- M9 
component of gp120-M9 was found to be competed out for its binding to gp120 by 
CD4D12. Immunological characterization of gp120 and its single chain derivatives in 
guinea pigs showed that all three molecules were highly immunogenic. Broadly 
neutralizing responses were observed only from sera generated against gp 120-CD4D 12, 
however the sera contained high titer of anti-CD4 antibodies. The antisera, when depleted 
for anti-CD4D12 antibodies, showed a loss of broadly neutralizing activity. Sera that 
were affinity purified over a column containing immobilized gp120-M9 also lacked such 
neutralizing activity. This suggests that the observed broadly neutralizing response is 
exclusively due to anti-CD4 antibodies. Only antisera generated against gp  120-CD4D 12 
competed with the CD4, antibody 17b and this activity was unaffected by depletion of 
anti-CD4 antibodies. The data indicate that although antibodies targeting the CD4i 
epitope were generated by the gp120-CMD12 immunogen, these antibodies were non- 
neutralizing. 
Chapter 6 discusses the attempts to introduce disulfide connectivity between gp120 and 
CD4 in nun-covalent complex as well as the single chain derivatives of gp120. The 
locations to introduce Cys residues to form putative disulfide were predicted using the 
program MODIP (Sowdhamini et al. 1989). Several different constructs were designed. 
All the constructs were expressed by transient transfixtion into 293 cell lines and 
purified using affinity chrarnatography using Lentil-Leetin Sepharose 4B. muified 
protein was labeled with thiol specific p m b  MPB to detect the presence of free thiols. 
gp12O-CWD12 (430-59) derivative in which residue 76430 in gpf 20 and U 9  in 
CD4D12 is replaced with Cys residue did m t  bind to MPB indicating the absence of my 
frcc thiols and the presence 01' a gp 120-CD4 intcrsubunit disulfide. None of the gp 120- 
M9 derivative was found to conta~n intersubunit disullidc. ,Activity of all the mutants was 
confirmed by their ability to ~nteract with 17b using SPR. All of the gp120-CD4D12 
single chain derivative werc found to interact with gp120 though with relat~vcly weaker 
affinity as compared to wt gp 120-CD4D 12. gp120-CD4D 12 (430-59) had higher activity 
than the other mutants. gp 120-M9 mutants showed weaker affllnity than wt gp 120-M9. In 
order to minimize CD4 specific immune responses the single chain derivative of gp120 
was constructed with domain D I of CD4Df 2 and characterized for its ability to bind with 
17b. 
